Ann: ATL1102 DMD Clinical Trial Application Submitted in Europe, page-26

Let me put it in simple terms

FMG was an unloved stock
Twiggy Forrest was not trusted because of the failed nickel (Annaconda)
Anp shares that sentiment.( no ROI for the past 15 yrs)

Why is Anp a no brainer ?
It’s like watching a sporting replay
We already know the results.
(All we have to do is replicate the last trial “Endpoint’s)

Why do we know our future earnings ?
Proved : Sarepta earnings in the US
Anp will capture the US and European markets .

Limb Girdle our new indication:
Market over $4 billion( treated with Corticosteroids)

Sleeping giant $$$$
Long Covid
why?
Because it will bring great exposure to Atl1102